tradingkey.logo
tradingkey.logo
Search

Amgen Inc

AMGN
Add to Watchlist
393.160USD
+7.510+1.95%
Close 09-21 16:00ET
212.63BMarket Cap
27.15P/E TTM
After-hours 17:43 (ET)392.000USD-1.180-0.30%

Amgen Inc (AMGN) Stock Price Target & Forecast

Analyst Rating

Based on 37 analysts giving stock ratings to Amgen Inc in the past month.

Hold
4 Strong Buy
12 Buy
18 Hold
2 Sell
1 Strong Sell
Target Price
389.145USD+0.91%

AMGN Analyst Recommendation Trends

In the current month, AMGN has received 12 Buy Ratings, 18 Hold Ratings, and 2 Sell Ratings. AMGN average Analyst price target in the last month is 389.145.

2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
Strong Buy
4
4
4
4
4
4
5
5
Buy
12
12
12
12
12
13
12
12
Hold
18
18
19
18
17
15
15
15
Strong Sell
1
1
1
1
1
1
1
1
Sell
2
2
2
2
2
2
2
2
Total
37
37
38
37
36
35
35
35

AMGN Analyst Rating for Peer Comparison

Updated: Sep 21, 2026
Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Ratings
Analysts
Biogen Inc
BIIB
7
17
12
1
0
37
Eli Lilly and Co
LLY
10
17
6
1
0
34
AbbVie Inc
ABBV
8
19
6
0
0
33
Regeneron Pharmaceuticals Inc
REGN
6
15
11
0
0
32
Merck & Co Inc
MRK
8
14
10
0
0
32
Pfizer Inc
PFE
5
6
19
1
1
32
Gilead Sciences Inc
GILD
7
18
6
0
0
31
Vertex Pharmaceuticals Inc
VRTX
9
16
5
0
1
31
Bristol-Myers Squibb Co
BMY
5
6
18
2
0
31
Alnylam Pharmaceuticals Inc
ALNY
5
18
7
0
0
30

Financial Forecasting

Based on analysts' estimates, AMGN EPS is projected to reach 5.786 in FY2026Q3, following reported EPS of 4.398 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.

EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
4.73
4.76
5.62
5.79
5.80
Actual
2.48
3.37
4.40
--
--
Surprise
-47.66%
-29.19%
-21.68%
--
--

FAQs

What is Amgen Inc's expected revenue for the next quarter?

Amgen Inc's expected revenue is 10.04B.

What is Amgen Inc's price target?

Analysts forecast that Amgen Inc's price target is USD 389.14, with the highest forecast at USD 457.00 and the lowest forecast at USD 225.00.

How have Amgen IncAMGN's recent earnings per share performed?

The market expectation was USD 4.40, while Amgen IncAMGN's earnings per share (EPS) for the previous quarter was USD 3.37. EPS for the next quarter is expected at USD 5.79.

What is the analyst rating for Amgen Inc?

Based on the ratings of Amgen Inc's stock from 37 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.